S

Sensei Bio

37 employees

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

Basic info

Industry

biotechnology research

Sectors

Cancer vaccines
Biotechnology
Health Diagnostics
Therapeutics
Antibodies
Medical
Chimeric Antigen Receptor - T Cells
Immuno-oncology
Companion diagnostics
Life Science

Date founded

1999

Funding rounds raised

Total raised

$30M

from 12 investors over 12 rounds

S

Sensei Bio raised $30M on January 11, 2021

Investors: infinitas capital, Catalio Capital Management, Korify Capital AG, Cambrian Bio, Apeiron Investment Group, Future Ventures, Presight Capital and Pura Vida Investments

S

Sensei Bio raised $29M on October 7, 2020

Investors: Future Ventures, Cambrian Bio, Presight Capital and Apeiron Investment Group

FAQ